Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

Developing New Antibiotics: What's the Best Approach to Take?

AUG 22, 2017 | CONTAGION® EDITORIAL STAFF


Daniel Pilch, PhD, associate professor in the Department of Pharmacology at Rutgers Robert Wood Johnson Medical School, co-founder of TAXIS Pharmaceuticals, discusses the three choices that developers have when it comes to the approach they can take for developing a new antibiotic. Dr. Pilch shares the two areas in which he and his team's approach to treating drug-resistant bacteria has been focused.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
Big advances in treatment can